We are committed to finding a cure for WM.

Medical News Today

WhimSICAL July 20 Update!

WMFC Members, we received the following update on the WhiMSICAL program. Your participation is highly encouraged. Thank you for the support!

Waldendstom’s Macroglobulinemia Study Involving CArt-WheeL

a world-first, ethically-approved, comprehensive survey of patient –… Continue reading

Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management

http://onlinelibrary.wiley.com/doi/10.1002/ajh.24557/full

Get the PDF Here –

Gertz-2017-Annual Clinical Updates in Hematological Malignancies

Abstract

Disease Overview: Waldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include anemia, thrombocytopenia, hepatosplenomegaly, lymphadenopathy, and rarely hyperviscosity.

Diagnosis: Presence… Continue reading

Mayo Clinic Update on Diagnosis and Treatment of WM

 

 

 

 

 

This open source article was recently published in the American Journal of Hematology. 

Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management

Authors

  • Morie A. Gertz
  • First published: 

 

WEBSITE

PDF

Health Canada Approves IMBRUVICA

IMBRUVICA® is an oral, once-daily, single-agent therapy associated with a durable response in patients with this rare B-cell lymphoma

TORONTOMay 12, 2016 /CNW/ – Janssen Inc. announced today that Health Canada has issued… Continue reading